Kyntra Bio, Inc.(KYNB)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | Wettig Thane CEO | Purchase | +2,800 | +4.33%67,468 | $7.09 | $19,852 | View SEC filing | |
| 2026-05-18 | Wettig Thane CEO | Purchase | -2,800 | -4.15%64,668 | $7.09 | $19,852 | View SEC filing | |
| 2025-11-17 | Wettig Thane CEO | Purchase | +3,700 | +17.39%24,979 | $9.12 | $33,750 | View SEC filing | |
| 2025-07-02 | Schoeneck James A Director | Purchase | +23,567 | +146.39%39,666 | $5.07 | $119,485 | View SEC filing | |
| 2025-03-25 | Wettig Thane CEO | Purchase | +145,000 | +36.31%544,329 | $0.35 | $50,663 | View SEC filing | |
| 2025-03-24 | Schoeneck James A Director | Purchase | +300,000 | +292.72%402,488 | $0.35 | $105,040 | View SEC filing | |
| 2024-06-13 | Adib Deyaa Chief Medical Officer | Purchase | +22,123 | +36.87%82,123 | $1.17 | $25,884 | View SEC filing | |
| 2024-03-11 | Wettig Thane CEO | Purchase | +50,000 | +11.87%471,178 | $1.91 | $95,470 | View SEC filing | |
| 2023-09-06 | Henderson Jeffrey William Director | Sale | -2,000 | -6.48%28,866 | $1.03 | $2,060 | View SEC filing | |
| 2023-08-08 | Henderson Jeffrey William Director | Sale | -2,000 | -6.09%30,866 | $1.91 | $3,820 | View SEC filing | |
| 2023-07-13 | Henderson Jeffrey William Director | Sale | -2,000 | -5.74%32,866 | $2.69 | $5,380 | View SEC filing | |
| 2023-07-10 | Conterno Enrique A Chief Executive Officer | Sale | -1,880 | -0.46%402,522 | $2.80 | $5,264 | View SEC filing | |
| 2023-06-26 | Wettig Thane Chief Commercial Officer | Sale | -791 | -0.73%108,261 | $16.53 | $13,075 | View SEC filing | |
| 2023-06-22 | Wettig Thane Chief Commercial Officer | Sale | -1,758 | -1.59%109,052 | $17.04 | $29,951 | View SEC filing | |
| 2023-06-15 | Chung Christine SVP, China Operations | Sale | -12,500 | -5.02%236,327 | $17.19 | $214,925 | View SEC filing | |
| 2023-06-09 | Cravatt Benjamin Director | Sale | -3,944 | -12.07%28,736 | $17.17 | $67,717 | View SEC filing | |
| 2023-06-09 | Brennan Aoife Director | Sale | -4,733 | -14.48%27,947 | $17.19 | $81,367 | View SEC filing | |
| 2023-06-09 | Blaug Suzanne Director | Sale | -8,520 | -22.35%29,594 | $17.20 | $146,571 | View SEC filing | |
| 2023-06-09 | Ho Maykin Director | Sale | -8,520 | -21.29%31,501 | $17.44 | $148,591 | View SEC filing | |
| 2023-06-09 | EDWARDS JEFFREY L Director | Sale | -7,889 | -18.84%33,977 | $17.19 | $135,622 | View SEC filing | |
| 2023-06-09 | Henderson Jeffrey William Director | Sale | -7,000 | -16.72%34,866 | $17.46 | $122,185 | View SEC filing | |
| 2023-06-09 | Schoeneck James A Director | Sale | -7,100 | -8.78%73,722 | $18.03 | $127,987 | View SEC filing | |
| 2023-06-09 | Wettig Thane Chief Commercial Officer | Sale | -1,758 | -1.55%111,395 | $17.04 | $29,951 | View SEC filing | |
| 2023-06-09 | Graham Juan Chief Financial Officer | Sale | -1,785 | -2.45%71,083 | $16.99 | $30,320 | View SEC filing | |
| 2023-06-09 | Chung Christine SVP, China Operations | Sale | -3,633 | -1.44%248,827 | $17.04 | $61,894 | View SEC filing |
1-25 of 349